Nanoscope Therapeutics says that, following a productive FDA meeting with the US Food and Drug Administration (FDA) for its ...

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Applications for AVT03, a proposed ...

US pharma giant Pfizer today released positive top line results from the final prespecified overall survival (OS) analysis of ...

Johnson & Johnson’s Tecvayli (teclistamab) has been recommended by NICE as a first-line treatment for myeloma in England and ...

GSK (LSE: GSK) has settled 93% of Zantac (ranitidine) product liability cases in the USA, agreeing to pay up to $2.2 billion ...

Insitro has signed three strategic agreements with Eli Lilly aimed at advancing treatments for metabolic diseases like MASLD, ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Part 1 of the New Drug Application ...

China's Quantum Pharmaceuticals has announced a major licensing deal between its subsidiary Ailux Biologics and Johnson & ...

Black Diamond Therapeutics (Nasdaq: BDTX) is restructuring to focus on its lead drug, BDTX-1535, aimed at non-small cell lung ...

Gene therapy start-up GEMMA Biotherapeutics has partnered with Brazil's Fiocruz in a deal worth up to $100 million, aiming to ...

Beijing’s InnoCare Pharma has announced promising Phase II results for its TYK2 inhibitor, ICP-488, in moderate-to-severe ...

Yesterday, the US Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), ...